Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Epidermal growth factor receptor erbB1 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Paraganglioma 2 D010235 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109390